Key Highlights

  • MDWerks (OTC: MDWK) expanded its board from five to six directors, appointing Jeffrey Scott Hopmayer as an independent director.
  • The company issued Hopmayer 500,000 shares of common stock as part of his compensation package.
  • Hopmayer will receive $5,000 quarterly, plus additional shares valued at $30,000 each quarter.
  • His term runs for three years, with expenses over $500 requiring preapproval.

Board Expansion Announced

MDWerks (OTC: MDWK) has increased its board of directors from five to six members, marking a strategic leadership adjustment. The move follows a regulatory filing that disclosed the appointment of a new independent director to strengthen governance oversight.

New Director Appointed

Jeffrey Scott Hopmayer was named as the sixth director, filling the newly created vacancy. The company confirmed his role as independent under SEC and Nasdaq standards, with no prior arrangements influencing his selection.

Compensation Structure

Hopmayer’s three-year term includes a quarterly cash payment of $5,000, paid in the third month of each quarter. His package also features an upfront grant of 500,000 shares of MDWerks common stock, with a par value of $0.001 per share.

Quarterly Stock Bonuses

In addition to the initial share grant, Hopmayer will receive quarterly stock bonuses. Each bonus equals $30,000 worth of common stock, calculated using a volume-weighted average price (VWAP) schedule.

Expense Reimbursement Terms

The company will reimburse Hopmayer for reasonable out-of-pocket expenses incurred in his role. Any expenses exceeding $500 require prior approval from MDWerks leadership.

Legal and Confidentiality Terms

Hopmayer’s agreement includes confidentiality clauses and intellectual property provisions. All work product created during his tenure will belong to MDWerks, with disputes subject to arbitration in Henderson County, North Carolina.

Press Release Follows

MDWerks issued a press release on July 10, 2026, announcing the board changes. The filing also referenced Roy Milner’s appointment, though details on his role remain limited.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.